Nativis CEO Chris Rivera. (Emulate Photo) EMulate Therapeutics, a 20-year-old Bellevue, Wash.-based company developing radio frequency energy technology to treat a range of diseases, filed to go public Tuesday. The 7-person company, previously known as Nativis, has programs for aggressive...
Emulate Therapeutics
Auto Added by WPeMatico